FOLH1 and neoplasm: These observations are supported by further analyses utilizing [68Ga]Ga-PSMA-11 PET, demonstrating that higher tumor volume and lower PSMA-ligand uptake intensity prognosticate poorer overall survival (OS) in patients treated with [177Lu]Lu-PSMA-617 [9–12].